Kontributor
Biotechnology is a commercial use of living organisms. The major area of biotechnology is medicine, and related products, such as vaccines. Biotechnology is also used in agriculture and heavy industry, including mining, with products like biopesticides as well as ethanol. Many major pharmaceutical companies have a distinct department for biotech-based medications. Certain of these www.genotec-frankfurt.de/top-5-simple-virtual-deal-software-for-beginners/ drugs are derived from living organisms, while others are based on chemicals. This distinction is important since both industries have distinct risk profile.
A biotech company can be expensive to operate due to its extensive research and development. A successful drug can generate an impressive financial return. It can take a while before a new drug can reach the market. The FDA approval process can be complex and time-consuming. It requires preclinical testing in addition to clinical trials and quality control. According to Science Daily, only a tiny fraction of the substances that are tested are released to the market.
Biotech companies have the option to concentrate their efforts on technology partnerships, or develop their pharmaceutical assets which they then license to big pharmaceutical companies to manufacture and distribute. Most young biotechs choose the latter option since it could boost the revenue growth. However, it’s not without risk since they also have to pay for the costs of developing clinical products and regulatory approval, as well as insurance reimbursement negotiations and sales promotion. To limit these risks biotech companies often rely on strategic alliances with major pharmaceutical and smaller biotechnology platforms companies. The biotech ecosystem in Massachusetts for instance includes top universities, teaching hospitals, entrepreneur communities and venture capitalists.
